David Zaccardelli's Net Worth
$452 Million
Estimate Recalculated Nov 11, 2024 02:48AM EST
Who is David Zaccardelli?
David Zaccardelli has an estimated net worth of $452 Million. This is based on reported shares across multiple companies, which include UNITED THERAPEUTICS Corp, CEMPRA, INC., Verona Pharma plc, and Dova Pharmaceuticals Inc..
SEC CIK
David Zaccardelli's CIK is 0001627642
Past Insider Trading and Trends
2015 was David Zaccardelli's most active year for acquiring shares with 51 total transactions. David Zaccardelli's most active month to acquire stocks was the month of November. 2015 was David Zaccardelli's most active year for disposing of shares, totalling 98 transactions. David Zaccardelli's most active month to dispose stocks was the month of July. 2016 saw David Zaccardelli paying a total of $7,798,015.00 for 409,750 shares, this is the most they've acquired in one year. In 2016 David Zaccardelli cashed out on 222,500 shares for a total of $12,402,150.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
UNITED THERAPEUTICS Corp (UTHR) Snapshot price: $345.63
EVP & Chief Operating Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
$90.79 | -$4,604,135.00 | 1.54K |
Scheduled
|
May 13
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
|
—
|
0
|
$112.51 | -$186,860.00 | 1.38K |
Scheduled
|
Dec 29
| ||
Form 4
|
—
|
0
|
$111.87 | -$184,260.00 | 1.38K |
Scheduled
|
Dec 22
| ||
Form 4
|
—
|
0
|
$112.89 | -$188,340.00 | 1.38K |
Dec 15
| |||
Form 4
|
—
|
0
|
$113.05 | -$189,000.00 | 1.38K |
Scheduled
|
Dec 8
| ||
Form 4
|
—
|
0
|
$112.40 | -$186,400.00 | 1.38K |
Scheduled
|
Dec 1
| ||
Form 4
|
—
|
0
|
$108.83 | -$181,600.00 | 1.38K |
Scheduled
|
Nov 24
| ||
Form 4
|
—
|
0
|
$104.54 | -$86,960.00 | 1.38K |
Nov 17
| |||
Form 4
|
—
|
0
|
$108.91 | -$191,380.00 | 1.38K |
Scheduled
|
Nov 10
| ||
Form 4
|
—
|
0
|
$106.83 | -$183,080.00 | 1.38K |
Nov 3
| |||
Form 4
|
—
|
0
|
$99.08 | -$228,120.00 | 1.38K |
Scheduled
|
Oct 27
| ||
Form 4
|
—
|
0
|
$93.17 | -$64,220.00 | 1.38K |
Scheduled
|
Oct 6
| ||
Form 4
|
—
|
0
|
$99.02 | -$75,910.00 | 1.38K |
Scheduled
|
Sep 29
| ||
Form 4
|
—
|
0
|
$102.94 | -$83,760.00 | 1.38K |
Scheduled
|
Sep 22
| ||
Form 4
|
—
|
0
|
$107.99 | -$187,700.00 | 1.38K |
Scheduled
|
Sep 15
| ||
Form 4
|
—
|
0
|
$107.59 | -$186,120.00 | 1.38K |
Scheduled
|
Sep 8
| ||
Form 4
|
—
|
0
|
$102.84 | -$83,550.00 | 1.38K |
Scheduled
|
Sep 1
| ||
Form 4
|
—
|
0
|
$106.87 | -$183,240.00 | 1.38K |
Scheduled
|
Aug 25
| ||
Form 4
|
—
|
0
|
$114.32 | -$213,040.00 | 1.38K |
Scheduled
|
Aug 18
| ||
Form 4
|
—
|
0
|
$113.11 | -$208,200.00 | 1.38K |
Scheduled
|
Aug 11
| ||
Form 4
|
—
|
0
|
$116.16 | -$109,522.56 | 1.38K |
Scheduled
|
Jul 21
| ||
Form 4
|
—
|
0
|
$116.10 | -$471,600.00 | 1.38K |
Scheduled
|
Jul 14
| ||
Form 4
|
—
|
0
|
$113.96 | -$227,220.00 | 1.38K |
Scheduled
|
Jul 7
| ||
Form 4
|
—
|
0
|
$115.55 | -$233,600.00 | 1.38K |
Scheduled
|
Jun 30
| ||
Form 4
|
—
|
0
|
$121.52 | -$514,960.00 | 1.38K |
Scheduled
|
Jun 23
| ||
Form 4
|
—
|
0
|
$122.03 | -$519,000.00 | 1.38K |
Scheduled
|
Jun 16
| ||
Form 4
|
—
|
0
|
$117.64 | -$483,880.00 | 1.38K |
Scheduled
|
Jun 9
| ||
Form 4
|
—
|
0
|
$119.54 | -$499,080.00 | 1.38K |
Scheduled
|
Jun 2
| ||
Form 4
|
—
|
0
|
$119.83 | -$501,400.00 | 1.38K |
Scheduled
|
May 26
| ||
Form 4
|
—
|
0
|
$117.61 | -$483,640.00 | 1.38K |
May 19
| |||
Form 4
|
—
|
0
|
$118.60 | -$436,962.50 | 1.15K |
Scheduled
|
Apr 14
| ||
Form 4
|
—
|
0
|
$118.11 | -$533,880.00 | 1.15K |
Scheduled
|
Apr 9
| ||
Form 4
|
—
|
0
|
$115.36 | -$511,880.00 | 1.15K |
Scheduled
|
Apr 7
| ||
Form 4
|
—
|
0
|
$113.05 | -$493,440.00 | 1.15K |
Scheduled
|
Apr 2
| ||
Form 4
|
—
|
0
|
$111.91 | -$484,260.00 | 1.15K |
Scheduled
|
Mar 31
| ||
Form 4
|
—
|
0
|
$109.45 | -$464,600.00 | 1.15K |
Scheduled
|
Mar 26
| ||
Form 4
|
—
|
0
|
$114.26 | -$587,272.50 | 1.15K |
Scheduled
|
Mar 24
| ||
Form 4
|
—
|
0
|
$111.66 | -$513,280.00 | 1.15K |
Scheduled
|
Mar 19
| ||
Form 4
|
—
|
0
|
$112.42 | -$519,360.00 | 1.15K |
Scheduled
|
Mar 17
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
$102.63 | -$153,192.06 | 1.15K |
Scheduled
|
Feb 24
| ||
Form 4
|
—
|
0
|
$102.62 | -$420,200.00 | 1.15K |
Scheduled
|
Feb 17
| ||
Form 4
|
—
|
0
|
$98.39 | -$386,360.00 | 1.15K |
Scheduled
|
Feb 10
| ||
Form 4
|
—
|
0
|
$96.04 | -$367,600.00 | 1.15K |
Scheduled
|
Feb 3
| ||
Form 4
|
—
|
0
|
$98.64 | -$388,400.00 | 1.15K |
Scheduled
|
Jan 27
| ||
Form 4
|
—
|
0
|
$98.29 | -$385,560.00 | 1.15K |
Scheduled
|
Jan 20
| ||
Form 4
|
—
|
0
|
$92.40 | -$253,860.00 | 1.15K |
Scheduled
|
Jan 13
| ||
Form 4
|
—
|
0
|
$87.30 | -$225,815.00 | 1.15K |
Scheduled
|
Jan 6
| ||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CEMPRA, INC. No price found
Acting Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
| +615.38% | 40K |
$5.00 | $200,000.00 | 46.5K |
May 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Verona Pharma plc (VRNA) Snapshot price: $26.39
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.92% | -141.03K |
$4.39 | -$618,657.57 | 15.2M |
Scheduled
|
Nov 1 - Nov 4
| ||
Form 4
| +5.17% | 754.05K |
$4.24 | -$1,043,131.62 | 15.35M |
Scheduled
|
Oct 30 - Nov 1
| ||
Form 4
| -0.98% | -144.82K |
$4.38 | -$633,895.84 | 14.59M |
Scheduled
|
Oct 23 - Oct 25
| ||
Form 4
| -3.37% | -514.15K |
$4.38 | -$2,253,236.58 | 14.74M |
Scheduled
|
Oct 18 - Oct 22
| ||
Form 4
| -3.79% | -600.00K |
$3.76 | -$2,254,320.00 | 15.25M |
Scheduled
|
Sep 11
| ||
Form 4
| -2.46% | -400.00K |
$3.20 | -$1,280,688.98 | 15.85M |
Scheduled
|
Aug 12 - Aug 13
| ||
Form 4
| +3.08% | 485.2K |
$2.62 | -$824,776.00 | 16.25M |
Aug 7
| |||
Form 4
| -0.56% | -88.54K |
$1.93 | -$171,005.03 | 15.85M |
May 1
| |||
Form 4
| -2.92% | -480.20K |
$2.29 | -$1,101,482.76 | 15.94M |
Feb 1
| |||
Form 4
| -4.69% | -809.01K |
$1.74 | -$1,410,748.15 | 16.42M |
Nov 1
| |||
Form 4
| +4.87% | 800K |
—
|
—
| 17.23M |
Oct 20
| |||
Form 4
| -1.65% | -275.89K |
$2.52 | -$693,897.03 | 16.43M |
Aug 3 - Aug 7
| |||
Form 4
| -1.06% | -179.65K |
$2.64 | -$474,938.45 | 16.71M |
Aug 1 - Aug 2
| |||
Form 4
| -2.63% | -455.54K |
$2.58 | -$1,173,415.18 | 16.89M |
May 1
| |||
Form 4
| -2.44% | -432.93K |
$2.56 | -$1,107,083.48 | 17.34M |
Scheduled
|
Feb 1
| ||
Form 4
| -3.27% | -600.00K |
$2.12 | -$1,269,600.00 | 17.78M |
Scheduled
|
Dec 20
| ||
Form 4
| -2.59% | -487.76K |
$1.60 | -$782,804.83 | 18.38M |
Scheduled
|
Nov 1
| ||
Form 4
| +23.59% | 3.6M |
—
|
—
| 18.86M |
Sep 26
| |||
Form 4
| -3.78% | -600.00K |
$1.75 | -$1,050,000.00 | 15.26M |
Scheduled
|
Aug 9
| ||
Form 4
| -2.98% | -487.77K |
$0.67 | -$328,922.26 | 15.86M |
Scheduled
|
Aug 1
| ||
Form 4
| -0.20% | -32.90K |
$0.50 | -$16,307.22 | 16.35M |
Scheduled
|
May 3
| ||
Form 4
| -2.70% | -454.86K |
$0.52 | -$237,666.44 | 16.38M |
May 1
| |||
Form 4
| -0.04% | -6.26K |
$0.76 | -$11,849.40 | 16.84M |
Scheduled
|
Feb 1 - Feb 3
| ||
Form 4
| -2.92% | -506.90K |
$0.64 | -$324,475.82 | 16.85M |
Scheduled
|
Nov 1 - Nov 2
| ||
Form 4
| -0.10% | -17.66K |
$0.75 | -$13,284.37 | 17.35M |
Scheduled
|
Aug 3
| ||
Form 4
| -2.74% | -489.25K |
$0.78 | -$382,940.16 | 17.37M |
Scheduled
|
Aug 1 - Aug 4
| ||
Form 4
| -10.93% | -2.19M |
$0.89 | -$1,940,849.30 | 17.86M |
Scheduled
|
May 3 - May 4
| ||
Form 4
| -0.22% | -43.39K |
$1.14 | -$49,627.43 | 20.05M |
Scheduled
|
Mar 1
| ||
Form 4
| +2.70% | 529.1K |
—
|
—
| 20.09M |
Jan 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Dova Pharmaceuticals Inc. No price found
President & CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -76.65K |
—
|
—
|
0
|
Nov 12
| |||
Form 4
| -6.44% | -5.28K |
$27.90 | -$147,172.50 | 76.65K |
Scheduled
|
Oct 1
| ||
Form 4
| -11.31% | -10.45K |
$15.94 | -$166,608.49 | 81.92K |
Scheduled
|
Jul 2
| ||
Form 4
|
∞
| 92.37K |
$6.07 |
—
| 92.37K |
Dec 19 - Dec 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||